Wei Zhao1, Tong-Bing Chen1, Hui Wang1. 1. The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Abstract
OBJECTIVE: The aim of the present study was to assess the expression of the Ikaros transcription factor (IKZF1) in lung adenocarcinoma and investigate whether expression levels of Ikaros are correlated with lung adenocarcinoma progression. METHODS: We conducted a retrospective study of 325 cases of resected stage I pulmonary adenocarcinoma, in which histological subtyping was performed according to the 2015 World Health Organization classification. We performed immunohistochemical examinations to assess expression of Ikaros in pulmonary adenocarcinomas and evaluated the correlation between Ikaros expression and cancer progression. RESULTS: Immunohistochemical staining was heterogeneous, with the majority of well-differentiated and moderately differentiated lung adenocarcinomas being weakly positive and the majority of the poorly differentiated lung adenocarcinomas exhibiting strong positive staining. Higher expression of Ikaros was associated with tumor recurrence or metastasis. CONCLUSIONS: Ikaros is heterogeneously expressed in different subtypes of lung adenocarcinoma; higher expression of Ikaros was found to be associated with cancer progression.
OBJECTIVE: The aim of the present study was to assess the expression of the Ikaros transcription factor (IKZF1) in lung adenocarcinoma and investigate whether expression levels of Ikaros are correlated with lung adenocarcinoma progression. METHODS: We conducted a retrospective study of 325 cases of resected stage I pulmonary adenocarcinoma, in which histological subtyping was performed according to the 2015 World Health Organization classification. We performed immunohistochemical examinations to assess expression of Ikaros in pulmonary adenocarcinomas and evaluated the correlation between Ikaros expression and cancer progression. RESULTS: Immunohistochemical staining was heterogeneous, with the majority of well-differentiated and moderately differentiated lung adenocarcinomas being weakly positive and the majority of the poorly differentiated lung adenocarcinomas exhibiting strong positive staining. Higher expression of Ikaros was associated with tumor recurrence or metastasis. CONCLUSIONS:Ikaros is heterogeneously expressed in different subtypes of lung adenocarcinoma; higher expression of Ikaros was found to be associated with cancer progression.
Authors: C Virely; S Moulin; C Cobaleda; C Lasgi; A Alberdi; J Soulier; F Sigaux; S Chan; P Kastner; J Ghysdael Journal: Leukemia Date: 2010-04-15 Impact factor: 11.528
Authors: K Kishihara; J Penninger; V A Wallace; T M Kündig; K Kawai; A Wakeham; E Timms; K Pfeffer; P S Ohashi; M L Thomas Journal: Cell Date: 1993-07-16 Impact factor: 41.582